Pub Date : 2002-05-01DOI: 10.3928/1542-8877-20020501-10
A. Berrocal, P. Chen, S. Soukiasian
Terrien's marginal degeneration (TMD) is a rare form of corneal ectasia. Few case reports have documented hydrops of the cornea in patients with TMD. We present the first case known to us of corneal hydrops in TMD where there is stromal edema in addition to the aqueous cystic cavities, and the first case demonstrating ultrastructural anatomy of this entity by ultrasound biomicroscopy.
{"title":"Ultrasound biomicroscopy of corneal hydrops in Terrien's marginal degeneration.","authors":"A. Berrocal, P. Chen, S. Soukiasian","doi":"10.3928/1542-8877-20020501-10","DOIUrl":"https://doi.org/10.3928/1542-8877-20020501-10","url":null,"abstract":"Terrien's marginal degeneration (TMD) is a rare form of corneal ectasia. Few case reports have documented hydrops of the cornea in patients with TMD. We present the first case known to us of corneal hydrops in TMD where there is stromal edema in addition to the aqueous cystic cavities, and the first case demonstrating ultrastructural anatomy of this entity by ultrasound biomicroscopy.","PeriodicalId":19509,"journal":{"name":"Ophthalmic surgery and lasers","volume":"33 1","pages":"228-30"},"PeriodicalIF":0.0,"publicationDate":"2002-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73245607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2002-05-01DOI: 10.3928/1542-8877-20020501-09
S. Maswadi, P. Dyer, D. Verma, Wadah Jalabi, D. Dave
BACKGROUND AND OBJECTIVE To demonstrate suitability of moiré interferometry to assess and quantify laser-induced shrinkage of scleral collagen for buckling procedures. MATERIALS AND METHODS Scleral buckling of human cadaver eyes was investigated using a Coherent Ultrapulse CO2 laser. Projection moiré interferometry was employed to determine the out-of plane displacement produced by laser exposure, and in-situ optical microscopy of reference markers on the eye was used to measure in-plane shrinkage. RESULTS Measurements based on moiré interferometry allow a three dimensional view of shape changes in the eye surface as laser treatment proceeds. Out-of-plane displacement reaches up to 1.5 mm with a single laser spot exposure. In-plane shrinkage reached a maximum of around 30%, which is similar to that reported by Sasoh et al (Ophthalmic Surg Lasers. 1998;29:410) for a Tm:YAG laser. CONCLUSION The moiré technique is found to be suitable for quantifying the effects of CO2 laser scleral shrinkage and buckling. This can be further developed to provide a standardized method for experimental investigations of other laser sources for scleral shrinkage.
{"title":"An investigation of CO2 laser scleral buckling using moiré interferometry.","authors":"S. Maswadi, P. Dyer, D. Verma, Wadah Jalabi, D. Dave","doi":"10.3928/1542-8877-20020501-09","DOIUrl":"https://doi.org/10.3928/1542-8877-20020501-09","url":null,"abstract":"BACKGROUND AND OBJECTIVE\u0000To demonstrate suitability of moiré interferometry to assess and quantify laser-induced shrinkage of scleral collagen for buckling procedures.\u0000\u0000\u0000MATERIALS AND METHODS\u0000Scleral buckling of human cadaver eyes was investigated using a Coherent Ultrapulse CO2 laser. Projection moiré interferometry was employed to determine the out-of plane displacement produced by laser exposure, and in-situ optical microscopy of reference markers on the eye was used to measure in-plane shrinkage.\u0000\u0000\u0000RESULTS\u0000Measurements based on moiré interferometry allow a three dimensional view of shape changes in the eye surface as laser treatment proceeds. Out-of-plane displacement reaches up to 1.5 mm with a single laser spot exposure. In-plane shrinkage reached a maximum of around 30%, which is similar to that reported by Sasoh et al (Ophthalmic Surg Lasers. 1998;29:410) for a Tm:YAG laser.\u0000\u0000\u0000CONCLUSION\u0000The moiré technique is found to be suitable for quantifying the effects of CO2 laser scleral shrinkage and buckling. This can be further developed to provide a standardized method for experimental investigations of other laser sources for scleral shrinkage.","PeriodicalId":19509,"journal":{"name":"Ophthalmic surgery and lasers","volume":"70 1","pages":"221-7"},"PeriodicalIF":0.0,"publicationDate":"2002-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78708953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2002-05-01DOI: 10.3928/1542-8877-20020501-22
P. Harasymowycz
{"title":"CLINICAL GLAUCOMA MANAGEMENT: CRITICAL SIGNS IN DIAGNOSIS AND THERAPY","authors":"P. Harasymowycz","doi":"10.3928/1542-8877-20020501-22","DOIUrl":"https://doi.org/10.3928/1542-8877-20020501-22","url":null,"abstract":"","PeriodicalId":19509,"journal":{"name":"Ophthalmic surgery and lasers","volume":"27 1","pages":"264-264"},"PeriodicalIF":0.0,"publicationDate":"2002-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84600339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2002-05-01DOI: 10.3928/1542-8877-20020501-07
B. Khoobehi, Robert Grinstead, E. Passos
OBJECTIVE To investigate the use of the photosensitizer hypocrellin A as a photodynamic agent to occlude the choriocapillaris in the eyes of pigmented rabbits. METHODS Hypocrellin A (500 microg/kg) incorporated into liposomes was injected intravenously in pigmented rabbits. Ten to 15 minutes later, the retinas were irradiated with a dye laser (spot size, 2 mm; 10-60 mW; 10-60 seconds; fluences 3.2 to 95.5 J/cm2) at two wavelengths: yellow (568 nm) and red (647 nm). Fluorescein angiography was performed 2 and 24 hours later. Parallel controls were irradiated without a photosensitizer. Histology was performed immediately after the 24-hour angiogram. observed 24 hours after PDT in eyes subjected to yellow laser irradiation at 20 mW for 60 seconds (fluence, 38.2 J/cm2) and at higher powers for lesser durations: 30 mW for 40 seconds (fluence, 38.2 J/cm2), 40 mW for 20 seconds (fluence, 25.4 J/cm2), and 50 and 60 mW for 10 seconds (fluences, 15.9 and 19.1 J/cm2, respectively). Light microscopy showed occlusion of the choriocapillaris in all eyes with angiographic responses. Control eyes and eyes irradiated with the red laser revealed no angiographic or histologic changes. CONCLUSION Photodynamic therapy using liposomal hypocrellin A and the yellow laser of 568 nm was effective in occluding the choriocapillaris of pigmented rabbits.
{"title":"Experimental photodynamic effects of hypocrellin A on the choriocapillaris.","authors":"B. Khoobehi, Robert Grinstead, E. Passos","doi":"10.3928/1542-8877-20020501-07","DOIUrl":"https://doi.org/10.3928/1542-8877-20020501-07","url":null,"abstract":"OBJECTIVE\u0000To investigate the use of the photosensitizer hypocrellin A as a photodynamic agent to occlude the choriocapillaris in the eyes of pigmented rabbits.\u0000\u0000\u0000METHODS\u0000Hypocrellin A (500 microg/kg) incorporated into liposomes was injected intravenously in pigmented rabbits. Ten to 15 minutes later, the retinas were irradiated with a dye laser (spot size, 2 mm; 10-60 mW; 10-60 seconds; fluences 3.2 to 95.5 J/cm2) at two wavelengths: yellow (568 nm) and red (647 nm). Fluorescein angiography was performed 2 and 24 hours later. Parallel controls were irradiated without a photosensitizer. Histology was performed immediately after the 24-hour angiogram. observed 24 hours after PDT in eyes subjected to yellow laser irradiation at 20 mW for 60 seconds (fluence, 38.2 J/cm2) and at higher powers for lesser durations: 30 mW for 40 seconds (fluence, 38.2 J/cm2), 40 mW for 20 seconds (fluence, 25.4 J/cm2), and 50 and 60 mW for 10 seconds (fluences, 15.9 and 19.1 J/cm2, respectively). Light microscopy showed occlusion of the choriocapillaris in all eyes with angiographic responses. Control eyes and eyes irradiated with the red laser revealed no angiographic or histologic changes.\u0000\u0000\u0000CONCLUSION\u0000Photodynamic therapy using liposomal hypocrellin A and the yellow laser of 568 nm was effective in occluding the choriocapillaris of pigmented rabbits.","PeriodicalId":19509,"journal":{"name":"Ophthalmic surgery and lasers","volume":"14 1","pages":"207-13"},"PeriodicalIF":0.0,"publicationDate":"2002-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83641722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2002-05-01DOI: 10.3928/1542-8877-20020501-14
Takumi Kawano, M. Doi, M. Miyamura, K. Esaki, M. Sasoh, Y. Uji
MAI or MIRAgel is a hydrogel developed as a scleral buckling material. We identified upper lid masses and a limitation of supraduction in the left eye of a patient who was associated with extrusion and fragmentation of the MIRAgel episcleral exoplant 11 years after scleral buckling surgery. The material could not be removed completely because of fragmentation. Fragmentation and extrusion of MIRAgel may be rare, but periodic long-term follow-up examinations should be performed after this product has been used.
{"title":"Extrusion and fragmentation of hydrogel exoplant 11 years after scleral buckling surgery.","authors":"Takumi Kawano, M. Doi, M. Miyamura, K. Esaki, M. Sasoh, Y. Uji","doi":"10.3928/1542-8877-20020501-14","DOIUrl":"https://doi.org/10.3928/1542-8877-20020501-14","url":null,"abstract":"MAI or MIRAgel is a hydrogel developed as a scleral buckling material. We identified upper lid masses and a limitation of supraduction in the left eye of a patient who was associated with extrusion and fragmentation of the MIRAgel episcleral exoplant 11 years after scleral buckling surgery. The material could not be removed completely because of fragmentation. Fragmentation and extrusion of MIRAgel may be rare, but periodic long-term follow-up examinations should be performed after this product has been used.","PeriodicalId":19509,"journal":{"name":"Ophthalmic surgery and lasers","volume":"17 1","pages":"240-2"},"PeriodicalIF":0.0,"publicationDate":"2002-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83549325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2002-05-01DOI: 10.3928/1542-8877-20020501-19
A. Michaeli-Cohen, D. Rootman
Scleral fixation has become more popular and is now performed by surgeons all over the world. At present, there are no available foldable intraocular lenses (IOLs) with holes that would enable tying a suture on to their haptic. We describe a method for using an available 3-piece acrylic foldable IOL with PMMA haptics for scleral fixation. This enables surgeons to benefit from the advantages of a small incision in cases when there is no need to exchange a previously implanted rigid IOL.
{"title":"Scleral fixation of a foldable intraocular lens.","authors":"A. Michaeli-Cohen, D. Rootman","doi":"10.3928/1542-8877-20020501-19","DOIUrl":"https://doi.org/10.3928/1542-8877-20020501-19","url":null,"abstract":"Scleral fixation has become more popular and is now performed by surgeons all over the world. At present, there are no available foldable intraocular lenses (IOLs) with holes that would enable tying a suture on to their haptic. We describe a method for using an available 3-piece acrylic foldable IOL with PMMA haptics for scleral fixation. This enables surgeons to benefit from the advantages of a small incision in cases when there is no need to exchange a previously implanted rigid IOL.","PeriodicalId":19509,"journal":{"name":"Ophthalmic surgery and lasers","volume":"30 2","pages":"257-9"},"PeriodicalIF":0.0,"publicationDate":"2002-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72562303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2002-05-01DOI: 10.3928/1542-8877-20020501-03
A. Iwach, M. E. Delgado, M. Adachi, M. Makarewycz, P. Wong, N. Nguyen
OBJECTIVE To present a method for remodeling oversized blebs using the THC:YAG laser and describe its use in treating hypotony and bleb leaks. METHODS Retrospective medical record review of 13 patients who underwent holmium laser bleb revision. RESULTS Thirteen eyes of 13 patients were analyzed. All the patients had an oversized bleb and 2 patients presented an associated late-onset leaking bleb. Mean preoperative IOP was 4.1 mm Hg. THC:YAG laser energy was applied to the bleb to remodel and/or close the leak. After a mean follow up of 17.3 months, the mean IOP was 7.84 mm Hg +/- 2.3. Postsurgery complications included hyphema and the inadvertent rupture of a conjunctival microcyst. Visual acuity improved in 9 of the eyes and remained stable in 4 of the eyes. CONCLUSION The THC:YAG laser can be used effectively to sculpt large blebs, reduce symptoms associated with large blebs, increase IOP in hypotonous eyes, and under specific circumstances, close bleb leaks.
目的介绍一种利用THC:YAG激光治疗大泡的方法,并描述其在治疗低斜视和大泡渗漏中的应用。方法回顾性分析13例钬激光囊泡修补术患者的临床资料。结果对13例患者的13只眼进行了分析。所有患者均有一个过大的水泡,2例患者出现了相关的晚发性漏泡。术前平均IOP为4.1 mm Hg。THC:YAG激光能量应用于气泡以重塑和/或关闭泄漏。平均随访17.3个月后,平均IOP为7.84 mmhg +/- 2.3。术后并发症包括前房积血和结膜微囊肿的意外破裂。9只眼睛的视力改善,4只眼睛保持稳定。结论THC:YAG激光可有效地对大泡进行整形,减轻大泡的相关症状,提高低斜视眼的IOP,并在特定情况下关闭大泡渗漏。
{"title":"Filtering bleb modification with a THC:YAG (Holmium) laser.","authors":"A. Iwach, M. E. Delgado, M. Adachi, M. Makarewycz, P. Wong, N. Nguyen","doi":"10.3928/1542-8877-20020501-03","DOIUrl":"https://doi.org/10.3928/1542-8877-20020501-03","url":null,"abstract":"OBJECTIVE\u0000To present a method for remodeling oversized blebs using the THC:YAG laser and describe its use in treating hypotony and bleb leaks.\u0000\u0000\u0000METHODS\u0000Retrospective medical record review of 13 patients who underwent holmium laser bleb revision.\u0000\u0000\u0000RESULTS\u0000Thirteen eyes of 13 patients were analyzed. All the patients had an oversized bleb and 2 patients presented an associated late-onset leaking bleb. Mean preoperative IOP was 4.1 mm Hg. THC:YAG laser energy was applied to the bleb to remodel and/or close the leak. After a mean follow up of 17.3 months, the mean IOP was 7.84 mm Hg +/- 2.3. Postsurgery complications included hyphema and the inadvertent rupture of a conjunctival microcyst. Visual acuity improved in 9 of the eyes and remained stable in 4 of the eyes.\u0000\u0000\u0000CONCLUSION\u0000The THC:YAG laser can be used effectively to sculpt large blebs, reduce symptoms associated with large blebs, increase IOP in hypotonous eyes, and under specific circumstances, close bleb leaks.","PeriodicalId":19509,"journal":{"name":"Ophthalmic surgery and lasers","volume":"26 1","pages":"181-7"},"PeriodicalIF":0.0,"publicationDate":"2002-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83441315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2002-05-01DOI: 10.3928/1542-8877-20020501-05
T. Sharma, L. Gopal, J. Biswas, M. Shanmugam, P. Bhende, R. Agrawal, N. Shetty, N. Sanduja
BACKGROUND To report visual results of vitrectomy in Terson syndrome MATERIALS AND METHODS In 11 patients, 15 eyes underwent vitreous surgery for Terson syndrome. The mean follow up was 18.3 months. RESULTS An incomplete posterior vitreous separation was noted in 10 eyes (66.7%). An epiretinal membrane was present in 4 eyes (26.7%), and in 3 eyes, a retinal fold along the arcade was noticed. Significant visual improvement occurred in all eyes; visual acuity of 20/40 or better was achieved in 14 eyes (93.3%). Only 3 eyes developed lens opacity after surgery. CONCLUSION Vitrectomy in Terson syndrome provides excellent visual recovery. The complication rate, including the development of cataract, is low.
{"title":"Results of vitrectomy in Terson syndrome.","authors":"T. Sharma, L. Gopal, J. Biswas, M. Shanmugam, P. Bhende, R. Agrawal, N. Shetty, N. Sanduja","doi":"10.3928/1542-8877-20020501-05","DOIUrl":"https://doi.org/10.3928/1542-8877-20020501-05","url":null,"abstract":"BACKGROUND\u0000To report visual results of vitrectomy in Terson syndrome\u0000\u0000\u0000MATERIALS AND METHODS\u0000In 11 patients, 15 eyes underwent vitreous surgery for Terson syndrome. The mean follow up was 18.3 months.\u0000\u0000\u0000RESULTS\u0000An incomplete posterior vitreous separation was noted in 10 eyes (66.7%). An epiretinal membrane was present in 4 eyes (26.7%), and in 3 eyes, a retinal fold along the arcade was noticed. Significant visual improvement occurred in all eyes; visual acuity of 20/40 or better was achieved in 14 eyes (93.3%). Only 3 eyes developed lens opacity after surgery.\u0000\u0000\u0000CONCLUSION\u0000Vitrectomy in Terson syndrome provides excellent visual recovery. The complication rate, including the development of cataract, is low.","PeriodicalId":19509,"journal":{"name":"Ophthalmic surgery and lasers","volume":"1 1","pages":"195-9"},"PeriodicalIF":0.0,"publicationDate":"2002-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88680694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2002-05-01DOI: 10.3928/1542-8877-20020501-06
Akiko Mera Kurok, T. Kitaoka, H. Taniguchi, T. Amemiya
BACKGROUND AND OBJECTIVE One of the serious complications that may arise after macular hole (MH) surgery is a temporal visual fields (TVF) defect. We hypothesized that hyperbaric oxygen (HBO) therapy improves the visual field (VF) in these patients. MATERIALS AND METHODS Vitrectomy for MH was performed on 73 eyes from 1994 to 1997. TVF defect was detected in 19 eyes and, of that 19, 12 patients were followed. Seven patients were treated with HBO therapy and 5 were controls. HBO was performed for approximately 110 minutes a day with 100% oxygen inhalation and a maximum of 2.8 atmospheric pressure. This continued for 20 days. The preoperative VF determined by kinetic perimetry was considered to be 100%, and the VF following HBO therapy was compared with that standard. RESULTS We detected VF defect (postoperative VF area average 71.9+/-12.8% of the preoperative VF). In all 5 patients who had no HBO therapy, TVF defects remained, while the TVF recovered remarkably in all patients treated with HBO therapy. The VF recovered to 81.7+/-16.7% of the preoperative VF after 3 days of HBO, and to 91.6+/-15.8% months after HBO therapy. CONCLUSION We speculated that the cause of TVF defect is likely to be chorioretinal circulation disturbance during surgery, and that HBO activates the retinal cells and improves VF. We conclude that HBO is useful in the treatment of TVF defect after macular hole surgery.
{"title":"Hyperbaric oxygen therapy reduces visual field defect after macular hole surgery.","authors":"Akiko Mera Kurok, T. Kitaoka, H. Taniguchi, T. Amemiya","doi":"10.3928/1542-8877-20020501-06","DOIUrl":"https://doi.org/10.3928/1542-8877-20020501-06","url":null,"abstract":"BACKGROUND AND OBJECTIVE\u0000One of the serious complications that may arise after macular hole (MH) surgery is a temporal visual fields (TVF) defect. We hypothesized that hyperbaric oxygen (HBO) therapy improves the visual field (VF) in these patients.\u0000\u0000\u0000MATERIALS AND METHODS\u0000Vitrectomy for MH was performed on 73 eyes from 1994 to 1997. TVF defect was detected in 19 eyes and, of that 19, 12 patients were followed. Seven patients were treated with HBO therapy and 5 were controls. HBO was performed for approximately 110 minutes a day with 100% oxygen inhalation and a maximum of 2.8 atmospheric pressure. This continued for 20 days. The preoperative VF determined by kinetic perimetry was considered to be 100%, and the VF following HBO therapy was compared with that standard.\u0000\u0000\u0000RESULTS\u0000We detected VF defect (postoperative VF area average 71.9+/-12.8% of the preoperative VF). In all 5 patients who had no HBO therapy, TVF defects remained, while the TVF recovered remarkably in all patients treated with HBO therapy. The VF recovered to 81.7+/-16.7% of the preoperative VF after 3 days of HBO, and to 91.6+/-15.8% months after HBO therapy.\u0000\u0000\u0000CONCLUSION\u0000We speculated that the cause of TVF defect is likely to be chorioretinal circulation disturbance during surgery, and that HBO activates the retinal cells and improves VF. We conclude that HBO is useful in the treatment of TVF defect after macular hole surgery.","PeriodicalId":19509,"journal":{"name":"Ophthalmic surgery and lasers","volume":"102 1","pages":"200-6"},"PeriodicalIF":0.0,"publicationDate":"2002-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87306917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2002-05-01DOI: 10.3928/1542-8877-20020501-21
U. Raina, Deven Tuli, R. Arora, D. K. Mehta, R. Bansal
{"title":"Congenital cystic eyeball.","authors":"U. Raina, Deven Tuli, R. Arora, D. K. Mehta, R. Bansal","doi":"10.3928/1542-8877-20020501-21","DOIUrl":"https://doi.org/10.3928/1542-8877-20020501-21","url":null,"abstract":"","PeriodicalId":19509,"journal":{"name":"Ophthalmic surgery and lasers","volume":"54 1","pages":"262-3"},"PeriodicalIF":0.0,"publicationDate":"2002-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88413797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}